A new patent infringement suit has been filed against Medtronic and CoreValve targeting percutaneous aortic valve implantation technology. The lawsuit was brought by a cardiologist, Troy Norred, and alleges infringement of Norred’s United States Patent No. 6,482,228 (“the ’228 patent”) entitled, “Percutaneous Aortic Valve Replacement.” The ’228 Patent relates to a balloon catheter with an inverted umbrella shaped valve with frame members or ribs that move between a folded position and an unfolded position.
The lawsuit alleges that the ’228 patent is infringed by Medtronic’s CoreValve ReValving System. In November of last year, Edwards Lifesciences succeeded in the appeal of its patent infringement lawsuit targeting Medtronic’s CoreValve ReValving System.
The complaint and the asserted patent in Norred v. Medtronic are available here.